Table 1 Baseline characteristics of trachomatous trichiasis (TT) patients in the treatment and placebo groups.
| Total (%) | Treatment group (%) | Placebo group (%) | p Value | |
|---|---|---|---|---|
| Sex* | NS (0.410) | |||
| Male | 29 (26.6) | 16 (30.2) | 13 (23.2) | |
| Female | 80 (73.4) | 37 (69.8) | 43 (76.8) | |
| Total | 109 (100) | 53 (48.6) | 56 (51.4) | |
| Age (years)* | NS (0.188) | |||
| <40 | 20 (18.3) | 9 (17.0) | 11 (19.6) | |
| 40–49 | 17 (15.6) | 7 (13.2) | 10 (17.9) | |
| 50–59 | 31 (28.4) | 15 (28.3) | 16 (28.6) | |
| 60–69 | 26 (23.9) | 10 (18.9) | 16 (28.6) | |
| 70–79 | 15 (13.8) | 12 (22.6) | 3 (5.4) | |
| Total | 109 (100) | 53 (48.6) | 56 (51.4) | |
| TT at surgery† | NS (0.300) | |||
| epilated (no eyelashes)‡ | 40 (27.0) | 21 (29.2) | 19 (25.0) | |
| ⩽5 eyelashes (minor) | 67 (45.3) | 28 (38.9) | 39 (51.3) | |
| >5 eyelashes (major) | 41 (27.7) | 23 (31.9) | 18 (23.7) | |
| Total | 148 (100) | 72 (48.7) | 76 (51.4) | |
| Active trachoma† | NS (0.813) | |||
| TF or TI or both | 88/148 (59.5) | 41/72 (56.9) | 47/76 (61.8) | |
| Infection†§ | NS (0.993) | |||
| C trachomatis PCR+ | 13/144 (9.0) | 7/69 (10.1) | 6/75 (8.0) |
*Based on the number of patients.
†Based on the number of eyelids; no previous lid surgery for any study subject; TT defined as ⩾one inturned eyelash (es) touching the globe of the eye.
‡Epilated cases defined as eyelids that had entropion but no eyelashes touching the globe, not included in the minor or major categories.
§Denominator differed from the number of eyelids at baseline (148) because of loss of four conjunctival samples.